Correlation Between Ningbo MedicalSystem and Zhengping RoadBridge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Zhengping RoadBridge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Zhengping RoadBridge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Zhengping RoadBridge Constr, you can compare the effects of market volatilities on Ningbo MedicalSystem and Zhengping RoadBridge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Zhengping RoadBridge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Zhengping RoadBridge.

Diversification Opportunities for Ningbo MedicalSystem and Zhengping RoadBridge

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Ningbo and Zhengping is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Zhengping RoadBridge Constr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zhengping RoadBridge and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Zhengping RoadBridge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zhengping RoadBridge has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Zhengping RoadBridge go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Zhengping RoadBridge

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to under-perform the Zhengping RoadBridge. But the stock apears to be less risky and, when comparing its historical volatility, Ningbo MedicalSystem Biotechnology is 2.4 times less risky than Zhengping RoadBridge. The stock trades about -0.16 of its potential returns per unit of risk. The Zhengping RoadBridge Constr is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  313.00  in Zhengping RoadBridge Constr on October 11, 2024 and sell it today you would earn a total of  56.00  from holding Zhengping RoadBridge Constr or generate 17.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ningbo MedicalSystem Biotechno  vs.  Zhengping RoadBridge Constr

 Performance 
       Timeline  
Ningbo MedicalSystem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ningbo MedicalSystem Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ningbo MedicalSystem is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Zhengping RoadBridge 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zhengping RoadBridge Constr are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhengping RoadBridge sustained solid returns over the last few months and may actually be approaching a breakup point.

Ningbo MedicalSystem and Zhengping RoadBridge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningbo MedicalSystem and Zhengping RoadBridge

The main advantage of trading using opposite Ningbo MedicalSystem and Zhengping RoadBridge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Zhengping RoadBridge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zhengping RoadBridge will offset losses from the drop in Zhengping RoadBridge's long position.
The idea behind Ningbo MedicalSystem Biotechnology and Zhengping RoadBridge Constr pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements